Clinical Trial Update: Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

The document reports on the safety and preliminary activity of the investigational drug ORE1001 in a Phase 1/2 study for mild to moderate ulcerative colitis, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ORE1001

Snippet

Sponsor: Ore Pharmaceuticals, Inc. | Conditions: Mild to Moderate Ulcerative Colitis | Phase 1, Phase 2 | Status: UNKNOWN